Hepatitis B 1. Description of the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence). 2. Describe the determinants of health and explain how those factors contribute to the development of this disease. 3. Discuss the epidemiologic triangle as it relates to the communicable disease you have selected. Include the host factors, agent factors (presence or absence), and environmental factors. (The textbook describes each element of the epidemiologic triangle). 4. Explain the role of the community health nurse (case finding, reporting, data collecting, data analysis, and follow-up). 5. Identify at least one…show more content… In agreement is ………………….which state that “the speed at which inflammation and scarring take place varies between people. Some develop severe liver scarring (cirrhosis) within 20 years. In others, liver disease progresses slowly and does not become a major problem during their lifetime.”
Most people have an acute case of HBV and according to the Cleveland Clinic, 2014, “most acute (HBV) infections produce no symptoms”, so people can have an acute case of HBV and not know it. When symptom are present, they range widely in severity. Possible symptoms include: “Unusually light-colored stool; fever; unexplained fatigue that persists for weeks or months; gastrointestinal symptoms such as loss of appetite, nausea, and vomiting; abdominal pain; joint pain and jaundice” (CDC, 2014).
The severity of complication range from mild discomforts to death. According to the CDC, 2014 “approximately 15%–25% of people with chronic Hepatitis B develop serious liver problems, including liver damage, cirrhosis, liver failure, and liver cancer”. It is estimated that nearly one million people in the United States (US) have chronic HBV and approximately 3,000 people die yearly from HBV liver related problems. Since the introduction of the immunization in 1990 there has been more than a 80% reduction in the number of HBV cases here in the US. Globally, approximately 350 million people are estimated to have chronic HBV and there are an estimated 620,000 contributory